Two Sigma Securities’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$134K Buy
+14,033
New +$119K 0.01% 1265
2024
Q3
– Sell
-12,900
Closed -$29K – 3740
2024
Q2
$29K Buy
+12,900
New +$26K ﹤0.01% 2644
2024
Q1
– Sell
-16,864
Closed -$39.6K – 3741
2023
Q4
$39.6K Buy
+16,864
New +$31.1K ﹤0.01% 2634
2023
Q1
– Sell
-61,470
Closed -$81.8K – 3367
2022
Q4
$81.8K Buy
+61,470
New +$86.8K ﹤0.01% 2097

Other funds holding XERS

Two Sigma Securities's XERS Position: Q3 2026 in Review

Two Sigma Securities opened a new position in Xeris Biopharma Holdings (XERS) in Q3 2026: 14,033 shares worth $134K. The stake represents 0.01% of the portfolio and ranks #1265 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in XERS as recently as Q2 2024.

Two Sigma Securities first reported a position in XERS in Q4 2022 and has held it in 4 quarters since. 249 funds tracked by Wall St. Rank hold XERS as of Q3 2026.

  • Two Sigma Securities held 14,033 shares of Xeris Biopharma Holdings worth $134K as of Q3 2026.
  • Xeris Biopharma Holdings was a new Two Sigma Securities position in Q3 2026.
  • Xeris Biopharma Holdings made up 0.01% of Two Sigma Securities's portfolio in Q3 2026, its #1265 holding.
  • Two Sigma Securities first reported a position in Xeris Biopharma Holdings in Q4 2022 and has held it in 4 quarters since.
  • 249 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.

Based on Two Sigma Securities's 13F filing for Q3 2026, filed 16 Nov 2026.